According to the National Institute on Drug Abuse, between 40 and 60 percent of people treated for addiction will relapse. More striking still, over 85 percent revert to previous patterns of use within the first year of treatment. For heroin and nicotine specifically, that figure climbs to between 80 and 95 percent. The field's standard response is to frame these numbers as evidence that addiction is a chronic condition — comparable, as NIDA puts it, to hypertension or asthma. That comparison is meant to reduce stigma, and in that respect it serves a purpose. But it also normalizes a failure rate that, in any other area of medicine, would be driving urgent demand for better approaches. For the clients behind those statistics, and for the families affected, "chronic and managed" is not the outcome they came looking for.
The current standard of care for opioid addiction frequently involves medication-assisted treatment (MAT) using methadone or buprenorphine (Suboxone). These medications have a meaningful role in stabilizing clients, reducing harm, and supporting engagement in treatment. The clinical reality, however, is that methadone maintenance requires at least 12 months and in many cases extends indefinitely, with no established endpoint (Rockefeller Institute of Government, 2019; Psychiatric Services, 2014). For a significant number of clients, the treatment goal shifts from resolution to long-term pharmaceutical management. The root emotional and psychological drivers of the addiction often remain unaddressed.
Research published in the American Journal of Public Health offers a compelling counterpoint to the "addiction is forever" framework. In a landmark study, psychiatrist Lee Robins followed nearly 900 Vietnam veterans who had been addicted to heroin while deployed. Upon returning home — removed from the environment, relationships, and emotional conditions that had driven their use — approximately 90 percent ceased their addiction without formal treatment. Only 5 percent became re-addicted within a year (Robins, Davis, and Nurco, American Journal of Public Health, 1974). The finding challenged the prevailing view that heroin addiction was permanent and irreversible, and suggested something the field has been slow to fully absorb: that when the underlying conditions driving addictive behavior change, the addiction itself can dissolve.
ETT® is designed for clients who want a drug-free approach — one that works directly with the emotional and psychological conditions that sustain addictive behavior, rather than managing symptoms through ongoing pharmaceutical support. It is not a criticism of medication-assisted treatment, which serves an important function for many clients. It is an alternative pathway for those who are looking for something different.
ETT® starts from a different premise: that if the underlying emotional drivers of addictive behavior can be reached and resolved, the compulsion to use loses its source. That is not a claim that every client will respond the same way. It is a clinical hypothesis, supported by a growing body of practitioner observation, that is worth taking seriously.
